Provided by Tiger Trade Technology Pte. Ltd.

Vertex, Inc.

12.28
+0.17001.40%
Post-market: 12.450.1700+1.38%18:29 EDT
Volume:1.18M
Turnover:14.39M
Market Cap:1.99B
PE:-304.84
High:12.46
Open:11.96
Low:11.60
Close:12.11
52wk High:37.77
52wk Low:10.59
Shares:162.00M
Float Shares:70.11M
Volume Ratio:0.98
T/O Rate:1.68%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.0403
EPS(LYR):0.0444
ROE:-2.88%
ROA:0.47%
PB:8.07
PE(LYR):276.60

Loading ...

Vertex Director David DeStefano sells 6,460 Vertex shares worth $82,365.50

Reuters
·
Jun 02

Vertex CEO, CFO to present at William Blair Growth Stock Conference

Reuters
·
Jun 01

Tasmea frees escrowed shares tied to Vertex acquisition

TIPRANKS
·
Jun 01

Assessing Vertex Pharmaceuticals (VRTX) Valuation After Health Canada Review Progress For Suzetrigine

Simply Wall St.
·
May 29

Vertex Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
May 29

Armstrong installs Templok energy-saving ceilings at Swinerton Spokane office renovation, unlocking 48E tax credits

Reuters
·
May 29

Armstrong retrofits facilities with Templok energy-saving ceilings, taps federal energy storage tax credits

Reuters
·
May 29

Vertex to Cancel 2.8 Million Treasury Shares to Cut Dilution Risk

TIPRANKS
·
May 28

Vertex Corp. Launches ¥1 Billion Share Buyback to Boost Capital Efficiency

TIPRANKS
·
May 28

Health Canada Review Puts Vertex’s Suzetrigine And Valuation In Focus

Simply Wall St.
·
May 23

Vertex Pharmaceuticals Says New Pain Management Drug Is Under Review at Health Canada

Dow Jones
·
May 22

Vertex announces Health Canada acceptance of NDS for suzetrigine

TIPRANKS
·
May 22

J.P. Morgan Reaffirms Their Buy Rating on Vertex Pharmaceuticals (VRTX)

TIPRANKS
·
May 20

Vertex study shows only 12% of firms have fully integrated tax technology

Reuters
·
May 19

New Vertex Research Highlights Rising Revenue Risk from IT, Tax, and Finance Misalignment

GlobeNewswire
·
May 19

Vertex Steps Into Autoimmune Care: Mid-Stage Myasthenia Gravis Trial Shows Growing Pipeline Ambition

TIPRANKS
·
May 19

Vertex Corp launches long-term stock option plan for directors

TIPRANKS
·
May 18

Vertex Pharmaceuticals Inc. Stock Underperforms Friday When Compared To Competitors

Dow Jones
·
May 16

Daiwa Securities Adjusts PT on Vertex Pharmaceuticals to $555 From $561, Maintains Buy Rating

MT Newswires Live
·
May 15

Vertex Sees FY Net Y4.70B

Dow Jones
·
May 14